Accelerating the pace of engineered cell therapies, from lab to bedside
Kytopen is speeding up both discovery and delivery of engineered cell therapies with its transformative Flowfect platforms.
Kytopen is speeding up both discovery and delivery of engineered cell therapies with its transformative Flowfect platforms.
Delivering vaccines directly to the lungs can boost immune responses to respiratory infections or lung cancer, study finds.
Research on how water behaves in a proton channel provides possible new avenues for flu treatment.
Researchers develop a system to identify drugs that might be repurposed to fight the coronavirus in elderly patients.
Using this computational system, researchers can identify viral protein sequences that could make better vaccine targets.
Study suggests mechanical properties of spike proteins can predict infectivity and lethality of different coronaviruses.
Letting an algorithm decide which maintenance holes to test for evidence of coronavirus could improve pandemic containment efforts.
Unexpected findings in chemokine receptors once believed to be non-functional open up new fields of scientific inquiry.
With computer models and lab experiments, researchers are working on a strategy for vaccines that could protect against any influenza virus.
A CRISPR-based test developed at MIT and the Broad Institute can detect nearly as many cases as the standard Covid-19 diagnostic.
MIT course on the Covid-19 pandemic, available to the public online, brings together top experts to educate students on up-to-date science.
New book for the general public explains how novel viruses such as SARS-Cov-2 emerge and how we can fight them.
Over 8,000 tests were performed last week by MIT Medical.
Sequential immunization might be safer and more effective than the existing tetravalent vaccine.
Differently shaped RNA molecules allow HIV to express different genes from the same RNA sequence.